Aprotinin--still courting controversy

Lancet. 2008 Feb 9;371(9611):449-50. doi: 10.1016/S0140-6736(08)60212-3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aprotinin / adverse effects*
  • Aprotinin / therapeutic use
  • Cardiac Surgical Procedures* / mortality
  • Coronary Artery Bypass
  • Coronary Artery Bypass, Off-Pump
  • Hemostatics / adverse effects*
  • Hemostatics / therapeutic use
  • Humans
  • Kidney / drug effects
  • Product Surveillance, Postmarketing
  • Renal Insufficiency / chemically induced*
  • Serine Proteinase Inhibitors / adverse effects*
  • Serine Proteinase Inhibitors / therapeutic use

Substances

  • Hemostatics
  • Serine Proteinase Inhibitors
  • Aprotinin